Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had a revenue of 13.41M in the quarter ending Sep 30, 2024, with -11.77%. This bring the company's revenue in the last twelve months to 62.66M, Decreased 9.25%. In the fiscal year ending Dec 31, 2023, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had annual revenue of 58.61M with 16.32% growth.